![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 209/08 | (2006.01) |
C07D 209/08 | (2013.01) | ||
A61K 31/403 | (2006.01) | ||
A61P 31/12 | (2018.01) | ||
A61P 31/12 | (2006.01) | ||
A61P 31/14 | (2018.01) |
(11) | Patento numeris | 3630723 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 18728541.6 |
Europos patento paraiškos padavimo data | 2018-05-18 | |
(97) | Europos patento paraiškos paskelbimo data | 2020-04-08 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2022-08-24 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2018/063028 |
Data | 2018-05-18 |
(87) | Numeris | WO 2018/215315 |
Data | 2018-11-29 |
(30) | Numeris | Data | Šalis |
17172237 | 2017-05-22 | EP |
(72) |
BONFANTI, Jean-François , FR
KESTELEYN, Bart, Rudolf, Romanie , BE
BARDIOT, Dorothée, Alice, Marie-Eve , BE
MARCHAND, Arnaud, Didier, M , BE
COESEMANS, Erwin , BE
FORTIN, Jérôme, Michel, Claude , FR
MERCEY, Guillaume, Jean, Maurice , FR
RABOISSON, Pierre, Jean-Marie, Bernard , BE
|
(73) |
Janssen Pharmaceuticals, Inc. ,
1125 Trenton-Harbourton Road, Titusville, NJ 08560,
US
Katholieke Universiteit Leuven , Waaistraat 6, Bus 5105, 3000 Leuven, BE |
(54) | SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS |
SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS |